Scalpel Weekly News

Week of: August 19, 2013

IN THE NEWS


Compounded Sterile Products Recalled; Bacterial Bloodstream Infection Risk

The FDA is alerting health care providers and patients of a voluntary nationwide recall of all products produced and distributed for sterile use by Specialty Compounding, LLC, Cedar Park, TX. Click title to continue reading... 


 
MEDICAL ALERTS


Infusion Systems Recalled; Incorrect Pump Infusion Rate Value; Injury Potential

Iradimed Corporation is recalling its MRidium 3860+ Infusion Systems equipped with MRidium 1145 Dose Error Reduction System (DERS) Drug Library Kit. The MRidium 1145 Dose Reduction System (DERS) drug library kit is an accessory intended for use with the MRidium 3860+ Infusion Pump System. Click title to continue reading... 



Inferior Vena Cava Filter Recalled; Risk Filter May Be Implanted Backwards

Cordis Corporation Recalled its Optease Retrievable Inferior Vena Cava (IVC) Filter to correct the label to provide clarification and additional information to minimize the likelihood of implanting the filter backwards. This recall covers 33,000 units distributed in the United States between May 6, 2010, and April 2, 2013. Click title to continue reading...



Persistent Racial and Geographic Disparities in U.S. Infant Mortality

Infant mortality is defined as the death of an infant before his or her first birthday. The infant mortality rate (IMR) measures this occurrence per 1,000 live births. In addition to being a key marker of maternal and child health, the IMR has been called the most sensitive indicator of overall societal health. Click title to continue reading... 


  CASE ALERTS


When Evidence of Standard of Care is Inadmissible, JNOV Required

 A man was admitted to the Central Mississippi Medical Center, complaining of severe abdominal pain. A gastroenterologist treated the man for gastrointestinal bleeding, and a cardiovascular surgeon surgically repaired his ulcer. After approximately one week, the man was discharged.



Malpractice Bond Reduction and Advancement of Costs by Plaintiff’s Counsel

A daughter and her mother brought a medical malpractice action against a number of defendants who allegedly participated in the daughter's prenatal care. The mother and daughter alleged that the defendants' failure to recognize, report, or respond to a significant abnormality on an ultrasound examination performed on the mother resulted in her daughter's severe and permanent personal injuries. Click title to continue reading...



False Claims Act; Long-Term Care Pharmacy Billed for Controlled Substances

The United States has filed suit against PharMerica Corporation in the U.S. District Court for the Eastern District of Wisconsin. The lawsuit alleges that PharMerica violated the False Claims Act and the Controlled Substances Act by dispensing controlled drugs without valid prescriptions and causing claims for illegally dispensed drugs to be submitted to the Medicare program. Click title to continue reading...